T2 BIOSYSTEMS INC - COM (TTOO)

CUSIP: 89853L104

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / COM
Total 13F shares
11,025,045
Share change
-6,018,728
Total reported value
$27,563,970
Put/Call ratio
50%
Price per share
$2.50
Number of holders
52
Value change
-$10,645,069
Number of buys
25
Number of sells
36

Quarterly Holders Quick Answers

What is CUSIP 89853L104?
CUSIP 89853L104 identifies TTOO - T2 BIOSYSTEMS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of T2 BIOSYSTEMS INC - COM (TTOO) as of Q3 2019

As of 30 Sep 2019, T2 BIOSYSTEMS INC - COM (TTOO) was held by 52 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,025,045 shares. The largest 10 holders included GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, MORGAN STANLEY, BlackRock Inc., GAGNON SECURITIES LLC, GEODE CAPITAL MANAGEMENT, LLC, ESSEX INVESTMENT MANAGEMENT CO LLC, MILLENNIUM MANAGEMENT LLC, GRANAHAN INVESTMENT MANAGEMENT INC/MA, and MARSHALL WACE, LLP. This page lists 52 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.